首页> 外文期刊>Journal of oncology >CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells
【24h】

CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells

机译:CXCL7介导的人乳腺癌细胞中淋巴管生成因子VEGF-C,VEGF-D的刺激

获取原文
           

摘要

Increased expression of lymphangiogenesis factors VEGF-C/D and heparanase has been correlated with the invasion of cancer. Furthermore, chemokines may modify matrix to facilitate metastasis, and they are associated with VEGF-C and heparanase. The chemokine CXCL7 binds heparin and the G-protein-linked receptor CXCR2. We investigated the effect of CXCR2 blockade on the expression of VEGF-C/D, heparanase, and on invasion. CXCL7 siRNA and a specific antagonist of CXCR2 (SB225002) were used to treat CXCL7 stably transfected MCF10AT cells. Matrigel invasion assays were performed. VEGF-C/D expression and secretion were determined by real-time PCR and ELISA assay, and heparanase activity was quantified by ELISA. SB225002 blocked VEGF-C/D expression and secretion (). CXCL7 siRNA knockdown decreased heparanase (). Both SB225002 and CXCL7 siRNA reduced the Matrigel invasion (). The MAP kinase signaling pathway was not involved. The CXCL7/CXCR2 axis is important for cell invasion and the expression of VEGF-C/D and heparanase, all linked to invasion.
机译:淋巴管生成因子VEGF-C / D和乙酰肝素酶的表达增加与癌症的侵袭有关。此外,趋化因子可能修饰基质以促进转移,并且它们与VEGF-C和乙酰肝素酶相关。趋化因子CXCL7结合肝素和与G蛋白相连的受体CXCR2。我们研究了CXCR2阻断对VEGF-C / D,乙酰肝素酶和侵袭表达的影响。 CXCL7 siRNA和CXCR2的特异性拮抗剂(SB225002)用于治疗CXCL7稳定转染的MCF10AT细胞。进行基质胶侵袭测定。通过实时PCR和ELISA测定法测定VEGF-C / D的表达和分泌,并通过ELISA定量乙酰肝素酶活性。 SB225002阻断VEGF-C / D的表达和分泌()。 CXCL7 siRNA敲低降低了乙酰肝素酶()。 SB225002和CXCL7 siRNA均减少了Matrigel侵袭()。不涉及MAP激酶信号传导途径。 CXCL7 / CXCR2轴对于细胞侵袭以及与侵袭有关的VEGF-C / D和乙酰肝素酶的表达都很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号